• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Federal judge tosses class-action Guidant suit

Federal judge tosses class-action Guidant suit

February 18, 2011 By MassDevice staff

BSX, Guidant

Its Guidant Corp. subsidiary delivered a rare bit of good news for Boston Scientific Corp. (NYSE:BSX), after a federal judge in California once again tossed a would-be class-action lawsuit over recalled Guidant pacemakers.

Judge Manual Real of the U.S. District Court for Central California granted a Guidant motion to dismiss the case, ruling that “all plaintiff’s state law claims are preempted by federal law,” according to court documents.

The U.S. Supreme Court ruled in Riegel vs. Medtronic (2008) that once a medical device has been approved by the Food & Drug Administration, product liability lawsuits based on state tort laws have no standing — in other words, the federal approval preempts state law, provided that the device was cleared via the more-rigorous pre-market approval process rather than via the 510(k) predicate device protocol.

Lead plaintiff Theodore Cohen was implanted with Guidant’s Insignia Plus DR Model 1298, a Class III medical device that was approved “under the equivalent of” the PMA process, according to the documents.

It’s the second time Real has tossed the suit. In November 2010 the judge granted Guidant’s first motion to dismiss, but gave Cohen et al a chance to amend their complaint. Guidant moved for another dismissal the next month.

Real also found that the amended complaint was just as flawed as the first, because it failed to link any defect in the Insignia device with specific FDA regulations. Cohen, whose pacemaker is still functioning, also failed to prove that the device is defective, the judge wrote.

“Plaintiff has not provided any factual support in his complaint that there is a defect in his pacemaker, much less that a defect occurred as a result of defendant’s violation of FDA regulations related to his device,” he wrote. “Plaintiff’s pacemaker was implanted in 2004 and has not failed. Even if plaintiff were able to plead adequately a defect in his device that resulted from defendants’ violation of FDA requirements, plaintiff has suffered no harm.”

The decision follows the resolution of another Guidant case that didn’t end so well for Boston Scientific. Another federal judge in Minnesota last month added three years of probation to a $296 million plea deal between Guidant and the U.S. Justice Dept.

Filed Under: Legal News, News Well, Product Liability Tagged With: Boston Scientific, Cardiac Rhythm Management, Guidant Corp.

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy